Filter
157
Text search:
Preexposure
prophylaxis
Featured
Recommendations
13
New Publications
26
Language
Document type
No document type
59
Guidelines
45
Studies & Reports
34
Manuals
5
Strategic & Response Plan
5
Fact sheets
5
Training Material
1
Brochures
1
Situation Updates
1
Infographics
1
Countries / Regions
South Africa
6
Global
6
Philippines
4
Kenya
4
Africa
4
Zambia
3
Malawi
3
Asia
3
India
2
Namibia
2
Latin America and the Carribbean
2
Eastern Europe
2
Russia
2
Sierra Leone
1
Nigeria
1
Ethiopia
1
Ghana
1
Uganda
1
Brazil
1
Ukraine
1
Botswana
1
Lesotho
1
East and Southern Africa
1
South–East Asia Region
1
Western and Central Europe
1
Authors & Publishers
Publication Years
Category
Countries
32
Clinical Guidelines
16
Women & Child Health
5
Public Health
4
Pharmacy & Technologies
3
Key Resources
1
Toolboxes
HIV
103
COVID-19
8
Polio
2
Rapid Response
2
TB
2
Caregiver
2
NTDs
2
Health Financing Toolbox
2
Refugee
1
Specific Hazards
1
Global Health Education
1
Planetary Health
1
Pharmacy
1
Evidence shows that oral pre-exposure prophylaxis (PrEP) reduces the risk of contracting HIV during sexual intercourse by more than 90% when taken daily. It is for this reason the National HIV Prevention Strategy 2015-2020 (2018 Revision) emphasi
...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP
...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Esc Anna Nery 2024;28:e20240093